For Ray and Elaine Theriault of Chepachet, Rhode Island, life has been both a literal and figurative journey – one that they’ve happily undertaken together, fueled by an adventurous spirit.
Both natives of Providence, they first met in kindergarten. They became high school sweethearts before Ray went on to graduate from Providence College and Elaine from the nursing program at Rhode Island Hospital. They got married in 1966, and traveled the world together during the first 20 years of their 53-year marriage.
From Alaska to Panama and many places in between, they raised their two sons while moving 17 times during Ray’s career as an airman and Lieutenant Colonel in the Army. The early years included a tour in Vietnam and a period serving as a paratrooper for Ray, before he became a fixed wing and helicopter pilot. Elaine worked in general medical units in various US and Panama locations, as well for 19 years at United Health Care.
When Ray retired from the military, the couple settled back in Rhode Island and put their energy into a series of successful business ventures, including the first Mailboxes, Etc. franchise in the state and a real estate brokerage.
Now they’re facing a new journey together: the quest to help end Alzheimer’s.
Neither Ray nor Elaine have Alzheimer’s disease, or any cognitive impairment. Their involvement with the Memory and Aging Program at Butler Hospital first began when Elaine’s mother, who had Lewy Body Dementia, participated in one of the program’s studies.
After her passing, Elaine decided she wanted to be informed about her risk. So she volunteered for a research study and underwent screening for amyloid plaques in her brain, which are believed to lead to the development of Alzheimer’s. Ray followed suit and, as they’d done with everything else in their lives, they did it together.
They’re both now participants (as well as each other’s study partners) in ADNI-3, a five-year observational study aimed at determining the relationships between clinical, cognitive, imaging, genetic and biomarker characteristics of Alzheimer’s. The study includes people who are cognitively normal as well as those with mild cognitive impairment or early Alzheimer’s.
Ray and Elaine are both cognitively normal, though it was discovered through the study that one of them does have plaques in the brain.
“With her family history, I thought for sure that Elaine would have [the plaques]. But it turns out she didn’t – I did, and with no family history. It was a real surprise,” Ray said. “Elaine holds it over me all the time,” he finishes jokingly.
Ray isn’t showing any symptoms of Alzheimer’s, and thus far tests have indicated no further development of the plaques. He says he’s thankful for that, of course. But he’s also thankful for the opportunity to continue monitoring their development for several years through the study – and for the chance to contribute to research he hopes will lead to an end to Alzheimer’s someday soon.
“It’s something that’s going on so much around us at our age, and I feel [participating in the study] makes me very well versed to understand and talk about it, and more comfortable that I can handle the issues,” Ray says.
“I’m not crazy about the fact that I have the potential for Alzheimer’s, but it helps me understand it and I try to do things to help. Every day you see a different article on things you can do, and I can evaluate it based on what I hear and see through the study, and talking with people from the study group,” he says.
Elaine says she wishes others would better understand the advantages of participating in research and be less driven by fear.
“We find a lot of people don’t want to know their risk or don’t even want to get into a discussion about it. Some of them are surprised at how involved we’ve gotten and how much information we want to know,” she says.
“But it can actually really help to put your mind at ease. We had the gene testing done and found out neither one of us has any of the combination of genes that we would pass on to our kids, so that was comforting. And even if you find out something negative, like Ray did, now we have the ability to plan for that risk, both for ourselves and for our kids. It’s what the individual takes from it,” she says.
Both Ray and Elaine say they hope more people will get involved, and want to spread the word that raising your hand to participate does not mean you’ll have to do anything you don’t want to do. They also recommend finding someone to participate with, as they have done together.
“It’s really helpful to participate together. You can bounce questions off each other, and to be honest we’re happy we can do it, we’re fortunate we can and it’s kind of an honor to my side of the family, with it being so prevalent,” Elaine says.
“I would advise people to just take an exploratory trip to Butler and talk to the people at the Memory and Aging Program. There’s no commitment, it’s very professionally run and if it turns out you don’t’ want to do it, that’s fine,” Ray says. “But give yourself the opportunity to examine the possibility of getting involved with an Alzheimer’s study, on your own grounds and temperament and comfort level.“
To learn more about the Memory and Aging Program and how you can get involved, visit butler.org/memory.
URI, BayCare and Butler Hospital to test retinal scanning for early detection of Alzheimer’s disease
Study seeks 330 volunteers for clinical trials.
On New Year's day GoLocalProv announced that it had selected Stephen Salloway, M.D. as its Man of the Year for 2019. Dr. Salloway, a world leader in Alzheimer's research, is director of Neurology and the Memory and Aging Program at Butler Hospital and Martin M. Zucker...
Major Alzheimer’s Association grant to enable researchers to test a drug that could slow the progression of Alzheimer’s disease.
With a special combination of compassionate care and scientific inquiry, she’s part of the front-line fight to end Alzheimer’s.
Drug Studied at Butler Hospital’s Memory and Aging Program May Become First New Treatment for Alzheimer’s in 16 Years
Aducanumab maker Biogen seeking FDA review in early 2020; if approved, it will become the first drug to remove amyloid protein from the brain and slow the progression of Alzheimer’s disease (AD).
Dr. Hwamee Oh Named Director of Imaging Research for The Memory and Aging Program at Butler Hospital
Dr. Oh will research the use of imaging to detect Alzheimer’s before symptoms appear, offering patients a chance at early intervention.
Marc Archambault has early-onset Alzheimer’s disease, but that’s not stopping him from living his best life – or inspiring others to do the same.
With a powerful range of skills and an inspiring amount of passion, these women are engaging others in the fight against Alzheimer’s.
Susan Saccoccia-Olson knows a lot about Alzheimer’s; she’s lost both of her parents to the
devastating disease. Now, she’s fighting back.